Feng Zhi

10PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyRegenerative medicine (incl. stem cells)Biomechanics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 11, 2026
Acriflavine-empowered IR780-PTX albumin nanoparticles for reinforced synergistic photochemotherapy.

Dazhao Li, Tong Wang, Hongchao Liu

|Jun 26, 2024
Targeting the TRIM14/USP14 Axis Enhances Immunotherapy Efficacy by Inducing Autophagic Degradation of PD-L1.

Di Liu, Mengqiu Li, Zhiyao Zhao

|May 29, 2024
Unveiling the Pharmacological Role of Human Deubiquitinating Enzymes in Temozolomide Response of Glioblastoma Cells.

Chunguang Yang, Yifei Li, Qifan Wu

|Jul 29, 2022
Correction: Exosomal hsa_circ_0006859 is a potential biomarker for postmenopausal osteoporosis and enhances adipogenic versus osteogenic differentiation in human bone marrow mesenchymal stem cells by sponging miR-431-5p.

Feng Zhi, Yi Ding, Rong Wang

|May 04, 2022
Correction to: Carnosic acid potentiates the anticancer effect of temozolomide by inducing apoptosis and autophagy in glioma.

Naiyuan Shao, Jiahao Mao, Lian Xue

|Mar 02, 2021
Exosomal hsa_circ_0006859 is a potential biomarker for postmenopausal osteoporosis and enhances adipogenic versus osteogenic differentiation in human bone marrow mesenchymal stem cells by sponging miR-431-5p.

Feng Zhi, Yi Ding, Rong Wang

Pageof 2

Frequent Collaborators

1 joint publications

Jinkai Wang

1 joint publications

Qi Cao

1 joint publications

Yize Zhang

1 joint publications

Kunpeng Liu